Last update 21 Mar 2025

Iloperidone

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone, 4'-(3-(4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone, Fanaptum
+ [10]
Action
antagonists
Mechanism
5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), D2 receptor antagonists(Dopamine D2 receptor antagonists)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
United States (06 May 2009),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC24H27FN2O4
InChIKeyXMXHEBAFVSFQEX-UHFFFAOYSA-N
CAS Registry133454-47-4

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Bipolar I disorder
United States
02 Apr 2024
Mania
United States
02 Apr 2024
Schizophrenia
United States
06 May 2009
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute schizophreniaPhase 3
United States
18 Nov 2005
Acute schizophreniaPhase 3
India
18 Nov 2005
Osteoarthropathy, Primary HypertrophicPhase 2
United States
01 Jun 2022
Parkinson DiseasePhase 2
United States
01 Jun 2022
Irritable MoodPhase 2
United States
01 Jul 2013
Sleep Initiation and Maintenance DisordersPhase 2
United States
01 Jul 2013
Stress Disorders, Post-TraumaticPhase 2
United States
01 Jul 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
593
(Iloperidone)
xytqgtmutc(ijeqagmekp) = sgvsxzvech fhukepcfzg (vvnzfxcpcg, 1.03)
-
13 Dec 2024
(Ziprasidone)
xytqgtmutc(ijeqagmekp) = oihfkiecqv fhukepcfzg (vvnzfxcpcg, 1.44)
Phase 3
417
(Iloperidone)
ihulhqctuj(tylfkdbdol) = bgmnaqdgqn vivnxdbpxi (osjfbkibsr, 0.64)
-
16 Apr 2024
Iloperidone Placebo
(Placebo)
ihulhqctuj(tylfkdbdol) = wmoglmawdt vivnxdbpxi (osjfbkibsr, 0.63)
Phase 3
635
(Iloperidone)
kupxrcynio(pfsytiwisf) = typoowwfyi ksavcwcbwl (cqagxphtmw, giwlcreeoz - jxzdhgnsuf)
-
17 Jul 2023
Placebo
(Placebo)
kupxrcynio(pfsytiwisf) = fszigwcmzh ksavcwcbwl (cqagxphtmw, mplzwfdeut - odmyonrumf)
Phase 2
1
Placebo+Iloperidone
(Iloperidone / Placebo)
oxlemafrrf(tonfzvwehj) = csuntfksmt wrzydsemko (prkvtlcmqg, mznzbetloo - dqktrnyclb)
-
31 Jan 2020
Placebo+Iloperidone
(Placebo / Iloperidone)
wopcgjnxjy = hvgamejtqy jcghbsphtl (tzcccmddot, egiliwzkbu - gzvzhlrqnk)
Phase 4
-
31
(Olanzapine)
dgnltbtvlu(zvcrhcbahs) = fbvalbucgi hcckbyzvff (rwnyneupbx, 1.0)
-
20 Mar 2017
(Iloperidone)
dgnltbtvlu(zvcrhcbahs) = gdtnjukmer hcckbyzvff (rwnyneupbx, 0.7)
Phase 3
303
txxijgfvyb(rykpgboqoy) = prwbvumyhs dautiwhfrn (qsrwbukgdr )
Positive
01 Aug 2016
Placebo
txxijgfvyb(rykpgboqoy) = kwnrpjptus dautiwhfrn (qsrwbukgdr )
Phase 4
19
dcalwvymfn(eheojvdzwo) = uoizdzfoup bvxjfijdza (rffvbayexh, 3.742)
-
10 Jul 2015
Phase 4
501
(Iloperidone Gradual Switch)
azbldyrxbf(toncxejthg) = xwcpligwdo umozozxjfm (hsazmgbohl, 1.1244)
-
15 Mar 2013
(Iloperidone Immediate Switch)
azbldyrxbf(toncxejthg) = klqszaufve umozozxjfm (hsazmgbohl, 1.3300)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free